Genetic Risk Factors of the Autoimmune Diabetes Mellitus, their Significance and Function;Genetické Rizikové Faktory Autoimunitného Diabetes Mellitus, ich Význam a Funkcia

Casopis Lekaru Ceskych

Volumn 143, Issue 3, 2004, Pages 159-163

  Novota, Peter ^a,b   Cejkova P ^a   Cerna M ^a   Andel M ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Diabetes mellitus; Genetic risk factor; HLA; Insulin; Interleukin; MIC A

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; C PEPTIDE; C PEPTIDE ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN CLASS 2; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INSULIN ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICROSATELLITE DNA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE ANTIBODY; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL DESTRUCTION; CYTOKINE GENE; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; GENE; GENETIC POLYMORPHISM; GENETIC RISK; HEREDITY; HUMAN; IMMUNOGENETICS; IMMUNOPATHOGENESIS; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RELATED GENE A; MAJOR HISTOCOMPATIBILITY COMPLEX; PANCREAS ISLET BETA CELL; REVIEW; RISK FACTOR; TH1 CELL; VARIABLE NUMBER OF TANDEM REPEAT;

AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; INSULIN; INTERLEUKINS; RISK FACTORS;

EID: 1642291466     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Rotter, J. I., Rimoin, D. L.: Heterogeneity in diabetes mellitus-update, 1978. Evidence for further genetic heterogeneity within juvenile-onset insulin-dependent diabetes mellitus. Diabetes, 1978, 27, s. 599-605.
2. Rotter, J. L, Rimoin, D. L.: Diabetes mellitus: the search for genetic markers. Diabetes Care, 1979, 2, s. 215-226.
3. Caillat-Zucman, S., Garchon, H. J., Timsit, J. et al.: Age-dependent HLA genetic heterogeneity of type I insulin-dependent diabetes mellitus. J. Clin. Invest., 1992, 90, s. 2242-2250.
4. Krokowski, M., Bodalski, J., Bratek, A. et al: HLA class II-associated predisposition to insulin-dependent diabetes mellitus in a Polish population. Hum. Immunol., 1998, 59, s. 451-455.
5. Gambelunghe, G., Forini, F., Laureti, S. et al.: Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin. Endocrinol., 2000, 52, s. 565-573.
6. Kobayashi, T., Tamemoto, K., Nakanishi, K. et al.: Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care, 1993, 16, s. 780-788.
7. Geraghty, D. E.: Complete sequence and gene map of human major histocompatibility complex. Nature, 1999, 401, s. 921-923.
8. Thorsby, E.: Structure and function of HLA molecules. Transplant. Proc., 1987, 19, s. 29-35.
9. Nakahira, M., Ahn, H. J., Park, W. R. et al.: Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J. Immunol., 2002, 168, s. 1146-1153.
10. Ando, A., Inoko, H.: Structure and function of human transplantation antigens. Hum. Cell, 1988, 1, s. 361-374.
11. Yewdell, J. W., Bennink, J. R.: The binary logic of antigen processing and presentation to T cells. Cell, 1990, 62, s. 203-206.
12. Weber, S., Traunecker, A., Oliveri, F. et al.: Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature, 1992, 356, s. 793-796.
13. Thomson, G., Robinson, W. P., Kuhner, M. K. et al.: Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet., 1988, 43, s. 799-816.
14. Redondo, M. J., Kawasaki, E., Mulgrew, C. L. et al.: DR- and DQ-associated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*. J. Clin. Endocrinol. Metab., 2000, 85, s. 3793-3797.
15. Kockum, I., Sanjeevi, C. B., Eastman, S. et al.: Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes. Eur. J. Immunogenet., 1999, 26, s. 361-372.
16. Ahmed, S., Bennett, S. T., Huxtable, S. J. et al.: INS VNTR allelic variation and dynamic insulin secretion in healthy adult non-diabetic Caucasian subjects. Diabet. Med., 1999, 16, s. 910-917.
17. Stead, J. D., Buard, J., Todd, J. A., Jeffreys, A. J.: Influence of allele lineage on the role of the insulin minisatellite in susceptibility to type 1 diabetes. Hum. Mol. Genet., 2000, 9, s. 2929-2935.
18. Pugliese, A., Miceli, D.: The insulin gene in diabetes. Diabetes Metab. Res. Rev., 2002, 18, s.13-25.
19. McInnes, I. B., Gracie, J. A., Leung, B. P. et al.: Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol. Today, 2000, 21, s. 312-315.
20. Rothe, H., Jenkins, N. A., Copeland, N. G., Kolb, H.: Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J. Clin. Invest., 1997, 99, s. 469-474.
21. Rothe, H., Ito, Y., Kolb, H.: Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas. J. Mol. Med., 2001, 79, s. 190-197.
22. Hong, T. P., Andersen, N. A., Nielsen, K. et al.: Interleukin-18 mRNA, but not interleukin-18 receptor mRNA, is constitutively expressed in islet beta-cells and up-regulated by interferon-gamma. Eur. Cytokine Netw., 2000, 11. s. 193-205.
23. Frigerio, S., Hollander, G. A., Zumsteg, U.: Functional IL-18 Is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis. Horm. Res., 2002, 57, s. 94-104.
24. Rothe, H., Hausmann, A., Casteels, K. et al.: IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. J. Immunol., 1999, 163, s. 1230-1236.
25. Giedraitis, V., He, B., Huang, W. X., Hillert, J.: Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J. Neuroimmunol., 2001, 112, s. 146-152.
26. Kretowski, A., Mironczuk, K., Karpinska, A. et al.: Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes, 2002, 51, s. 3347-3349.
27. Trinchieri, G.: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev. Immunol., 1995, 13, s. 251-276.
28. O'Hara, R. M. Jr., Henderson, S. L., Nagelin, A.: Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann. NY Acad. Sci., 1996, 795, s. 241-249.
29. Zipris, D., Greiner, D. L., Malkani, S. et al.: Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. J. Immunol., 1996, 156, s.1315-1321.
30. Nicoletti, F., Di Marco, R., Zaccone, P. et al.: Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease. Immunology, 1999, 97, s. 367-370.
31. Davoodi-Semiromi, A., Yang, J. J., She, J. X.: IL-12p40 is associated with type 1 diabetes in Caucasian-American families. Diabetes, 2002, 51, s. 2334-2336.
32. Almawi, W. Y., Tamim, H., Azar, S. T.: Clinical review 103: T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J. Clin. Endocrinol. Metab., 1999, 84, s. 1497-1502.
33. Rapoport, M. J., Jaramillo, A., Zipris, D. et al.: Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice, J. Exp. Med., 1993, 178, s. 87-99,
34. Zheng, X. X., Steele, A. W., Hancock, W. et al.: A noncytolytic IL- 10/ Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol., 1997, 158, s. 4507-4513.
35. Go, N. F., Castle, B. E., Barrett, R. et al.: Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med., 1990, 172, s. 1625-1631.
36. Rousset, F., Garcia, E., Defrance, T. et al.: Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad, Sci. U S A, 1992, 89, s. 1890-1893.
37. Lee, M. S., Mueller, R., Wicker, L. S. et al.: IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med., 1996, 183, s. 2663-2668.
38. Pakala, S. V., Kurrer, M. O., Katz, J. D.: T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med., 1997, 186, s. 299-306.
39. Ide, A., Kawasaki, E., Abiru, N. et al.: Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset. Hum. Immunol., 2002, 63, s. 690-695.
40. Li, P., Willie, S. T., Bauer, S. et al.: Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity, 1999, 10, s. 577-584.
41. Fodil, N., Laloux, L., Wanner, V. et al.: Allelic repertoire of the human MHC class I MICA gene. Immunogenetics, 1996, 44, s. 351-357.
42. Bahram, S., Bresnahan, M., Geraghty, D. E., Spies, T.: A second lineage of mammalian major histocompatibility complex class I genes. Proc. Natl. Acad. Sci, USA, 1994, 91, s. 6259-6263.
43. Zwirner, N. W., Fernandez-Vina, M. A., Štastný, P.: MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics, 1998, 47, s. 139-148.
44. Groh, V., Steinle, A., Bauer, S., Spies, T.: Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science, 1998, 279, s. 1737-1740.
45. Bahram, S., Spies, T.: The MIC gene family. Res. Immunol., 1996, 147, s. 328-333.
46. Ota, M., Katsuyama, Y., Mizuki, N. et al.: Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens, 1997, 49, s. 448-454.
47. Gambelunghe, G., Ghaderi, M., Cosentino, A. et al.: Association of MHC Class I chain-related A (MIC-A) gene polymorphism with Type I diabetes. Diabetologia, 2000, 43, s. 504-514.